The Microplastic Research Group’s response to The Guardian feature
Recent media coverage, in particular The Guardian’s article “A bombshell’: doubt cast on discovery of microplastics throughout human body”, has suggested that parts of microplastics research may be flawed. From the perspective of researchers working in this field, this framing risks distorting how science actually progresses.
What is being portrayed as a credibility crisis, is in fact an essential part of the scientific process and shows that science is functioning as it should. Methods are questioned, weaknesses identified and analytical standards refined. It is not an indication that a research field is unreliable, but rather evidence that it is maturing.
In the case of microplastics research, there can be lots of analytical challenges. These challenges can pop up at different stages, from getting the samples to processing them in the lab and checking polymers with the right instrument. The main problems are contamination issues and whether the selected analysis method is suitable for the matrix of interest. If you don’t have a proper quality assessment and quality control protocol in place, you might end up misrepresenting the samples as being microplastic-free when they’re actually from another source. Also, if you don’t identify polymers using the right instrument, you might think every particle you see is a polymer.
Importantly, these approaches aren’t just random ideas. It’s all about the knowledge that gets added up over time as more and more researchers join in. For example, early microplastic studies didn’t really have quality control or instrumental analysis, but this didn’t change the fact that microplastic pollution is a problem. In fact, it got the attention of more researchers and set the stage for more detailed and consistent scientific studies.
We’re now seeing a similar process in studies on micro- and nanoplastics in the human body. But this time, the press is reporting the story in a slightly more sensational way because it will get more attention. But when science starts to shed more light on things, it’s hard to understand why the same studies are being discredited in such a general way. The brain study discussed in the aforementioned Guardian article is precisely analogous. As experts in this field, we approach such studies with a certain degree of caution due to the fact that misinformation disseminates more rapidly than accurate information. It is inevitable that studies employing a recently developed analytical method (e.g. chromatography-based nanoplastic detection) will exhibit certain deficiencies or inaccuracies. It is the scientific community, rather than the media, that will address these deficiencies with due diligence.
How these challenges are communicated beyond the scientific community matters. Framing the challenges of microplastics research as a ‘bombshell’ casts doubt on an entire body of research, teaching the public to distrust science for doing precisely what it should do. Legitimate methodological criticism should be articulated through precise technical language in peer-reviewed responses. Otherwise, when complex debates are reduced to inflammatory soundbites that dismiss studies as a ‘joke’, this results in greater confusion rather than clarity, undermining a whole field of study – even when the scientific process is functioning just as it should. Therefore, critically evaluating research in a field with an unstandardised methodology through the media without conducting further studies on the same topic is problematic from a scientific methodology perspective.
There is a long history of uncertainty creating regulatory delay, preventing action on issues with major public health and environmental implications. From tobacco to climate change, we have watched industries point to ongoing scientific debate as a reason to prevent progress in policymaking. Microplastics research is at risk of being drawn into a similar dynamic if methodological refinement is misrepresented as scientific failure.
Under the precautionary principle, scientific uncertainty should not be a reason for inaction. When there is credible evidence of potential harms of microplastics, this should build a case for more conservative regulations, not a ‘wait and see’ approach.
Responsible science journalism must distinguish between scientific refinement and scientific failure, to avoid turning a technical debate into a tool for industry-led paralysis that ends up undermining both public understanding and effective policy. At a moment when evidence-based decision-making is urgently needed, it is especially important to communicate scientific uncertainty with accuracy, context, and care.